ChemoCentryx Operating Expenses 2011-2026 | CCXI

Annual Operating Expenses ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	120 M	94.3 M	83.1 M	66 M	52.2 M	47.7 M	47.4 M	45.2 M	45 M	36 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
120 M	36 M	63.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	90.2 M	$ 8.52	6.57 %	$ 84.2 M	USA
BioNTech SE BNTX	512 M	$ 97.36	1.94 %	$ 27.2 B	Germany
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.57	-3.9 %	$ 8.59 B	Australia
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	216 M	$ 21.03	3.24 %	$ 983 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	173 M	$ 1.45	3.57 %	$ 373 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.99	2.4 %	$ 4.92 M	Israel
Aquestive Therapeutics AQST	85.5 M	$ 4.21	3.06 %	$ 450 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 24.08	-0.56 %	$ 3.06 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 32.41	0.51 %	$ 2.15 B	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.48	-1.01 %	$ 394 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	177 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	17.3 M	$ 4.13	5.36 %	$ 278 B	Britain
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	343 M	$ 2.18	0.46 %	$ 453 M	USA
Evogene Ltd. EVGN	13.8 M	$ 0.78	-4.39 %	$ 27.9 M	Israel
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	172 M	$ 3.23	3.04 %	$ 325 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA